![Michael J. McKenna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael J. McKenna
Corporate Officer/Principal chez
Harvard Medical School
Profil
Michael J.
McKenna was the founder of Akouos, Inc. since 2016, serving as Chief Surgical Officer.
Dr. McKenna is a Professor at Harvard Medical School since 1996.
Formerly, Chairman at Massachusetts Eye & Ear Infirmary, Inc. Education includes a doctorate from Keck School of Medicine of USC.
Postes actifs de Michael J. McKenna
| Sociétés | Poste | Début |
|---|---|---|
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1996 |
Anciens postes connus de Michael J. McKenna
| Sociétés | Poste | Fin |
|---|---|---|
Massachusetts Eye & Ear Infirmary, Inc.
 Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Provides vision and hearing treatments | Président | - |
| AKOUOS | Fondateur | - |
Formation de Michael J. McKenna
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
98
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Massachusetts Eye & Ear Infirmary, Inc.
Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Provides vision and hearing treatments | Health Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keck School of Medicine of USC
 Keck School of Medicine of USC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
